SHOPPING CART
REGISTER
LOGIN
SEARCH

Diagnostic Testing & Technology Report

September 2008

Bone Disease Marker May Predict Risk of Death in Dialysis Patients

High levels of alkaline phosphatase—a routinely measured laboratory marker of bone disease—may signal an increased risk of death in patients with chronic kidney disease (CKD), reports a study in the November Journal of the American Society of Nephrology (JASN). The study was published online on July 30.

Login | Subscribe

September 2008 - Table of Contents

DTTR September 2008 (full PDF issue)

In Planning Menu Additions, Labs Prioritize Genetic Testing

FDA Clears Pathwork Diagnostics Tumor Origin Test

Medicare Legislation Kills Lab Competitive Bidding Demo

AutoGenomics Files for IPO

Harms of Prostate Cancer Screening Outweigh Benefits for Men Over 75

Inverness Debuts Rapid HIV Test, Plans POC Molecular Test

Growing Field of Molecular Diagnostics Still Dominated by Infectious Disease Testing

FDA Clears Invitrogen�s CISH Test for HER2

HandyLab Raises $19M

Gene Express Partners With NeoGenomics for Test Validation, Commercialization

Gene Expression Predicts Lung Cancer Survival

New Assay Shows Promise for Anemia Diagnosis

Rosetta Genomics Completes Purchase of Parkway Clinical Labs

Bone Disease Marker May Predict Risk of Death in Dialysis Patients

Bill Calls for Overhaul of Medicare Lab Fee Schedule

Gene Variations Affect Response to Antidepressant Celexa

Private Equity Firm Buys GTI Diagnostics

Biomarkers Show Promise for Early Diagnosis of Alzheimer�s Disease

IVD Stocks Climb 14%; Clinical Data Soars 39%

Lab Institute 2008 to Tackle Changing of the Guard

Diagnostic Testing & Technology Report is part of...

Focus Areas	Product Group
G2 Reports Medical Lab Management	Newsletters